NCT01343030

Brief Summary

Breast implants are currently used for cosmetic breast augmentation and in breast reconstruction following mastectomy for breast cancer. Fat grafting is a technique where fat is injected around the periphery of a breast implant to camouflage the transition between implant and the body. The investigators propose to show mammography images of women who have had breast implants with fat grafting to informed and blinded radiologists and evaluate their readings of the images. Hypothesis: with mammographic screening, radiologists will be able to distinguish between findings associated with fat grafting and those which are suspicious for breast cancer.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2010

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2011

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 27, 2011

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2015

Completed
Last Updated

November 1, 2019

Status Verified

October 1, 2019

Enrollment Period

5.3 years

First QC Date

March 22, 2011

Last Update Submit

October 30, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiologist dictations of mammograms

    We will compare the Bi-Rad level score readings, and recommended follow-up of the blinded and non-blinded radiologist's read of study participants mammograms.

    We will obtain mammograms and MRIs of participants at intervals of 6 months for up to 24 months post fat grafting.

Study Arms (1)

Patients with implants

Patients with silicone implants and fat grafting.

Eligibility Criteria

Age18 Years - 84 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We will select patients from Clinique Spontini Paris France and from patients at the University of Minnesota USA who have undergone placement of silicone breast implants with fat grafting.

You may qualify if:

  • Women with silicone implants and fat grafting

You may not qualify if:

  • Procedures performed outside the University of Minnesota or Clinique Spontini Paris, France

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

Clinique SPONTINI

Paris, France

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Bruce L Cunningham, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2011

First Posted

April 27, 2011

Study Start

September 1, 2010

Primary Completion

December 31, 2015

Study Completion

December 31, 2015

Last Updated

November 1, 2019

Record last verified: 2019-10

Locations